Symposium 3: Deprescription Dynamics: Insights and Strategies for Optimizing Medication Management in Diverse Healthcare Landscapes
Tracks
Track 3
| Sunday, October 13, 2024 |
| 10:30 - 12:00 |
| Ito International Research Centre |
Details
The practice of deprescription, the systematic process of reducing or discontinuing medications that are no longer necessary or may be causing harm, has gained significant attention in recent years. This symposium proposal aims to explore the multifaceted aspects of deprescription, including its clinical, societal and economic implications. The session also addresses the preparedness of future healthcare professionals regarding their ability and confidence in deprescription. Experts from various fields will share their insights on deprescription strategies, challenges, and opportunities, fostering discussions on how to optimise medication use and improve patient outcomes.
The topic of deprescription is of paramount interest to ISPE's membership, particularly in the Asian region, due to several compelling reasons. Asia is undergoing rapid demographic changes, with projections indicating that by 2050, more than half of the world's older population will reside in this region. This demographic shift is accompanied by an increased prevalence of chronic diseases and polypharmacy, where patients are prescribed multiple medications concurrently. Such practices elevate the risks of adverse drug events, medication interactions, and unnecessary healthcare expenditures. Moreover, cultural influences often shape healthcare-seeking behaviors in Asia, contributing to higher rates of medication use and potentially inappropriate prescribing practices. Additionally, limited access to healthcare resources and primary care providers in certain Asian countries exacerbates the complexities associated with medication management. Therefore, exploring deprescription strategies tailored to the diverse healthcare landscapes and patient populations in Asia is imperative for promoting rational medication use, enhancing patient safety, and optimizing healthcare resources.
Speaker
Amal Anand
Clinical Research Scientist
The Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University
Presenter
Biography
I am a growing Clinical Reserch Scientist with a background in Pharmacoepidemiology and Clinical Research. With three years at Novartis as a Clinical Research Scientist focusing on pediatric oncology trials, I contributed significantly to advancing research initiatives. Proficient in Public Speaking, GCP, and Research, they demonstrate adaptability and cooperation. Currently pursuing a Master's in Clinical and Translational Science at Rutgers University, I work as a Research Assistant at the Rutgers Institute for Health, contributing to PETS. Holding a PharmD and a Post Graduate Diploma in Clinical Research, I excel in pharmacoepidemiology using tools like Medidata Rave and Oracle RDC. My commitment to impactful contributions in clinical research and healthcare is evident through diverse professional experience and academic endeavors.
Atiqulla Shariff
Research Scholar
JSS College of Pharmacy, Mysuru
Presenter
Biography
I am Atiqulla Shariff, pursuing a doctorate (PhD) in pharmacy practice at JSS College of Pharmacy, Mysuru. I have been the principal investigator for many pharmacoepidemiology and pharmacy practice studies. I have published fifteen pharmacoepidemiological research in peer-reviewed journals. My core research interest is drug use evaluation, and drug use in special populations. The current abstract is one of my research interests that focuses on consistency assessment between the drug information resources for the recommendations on drug use in renal impairment. This study is fascinating to me and many clinical pharmacists and healthcare providers alike because it focuses on drug use issues in renal impairment, as there is no gold standard reference available on renal drug dosage adjustment. Hopefully, the results of this study will ignite some policy changes, that can ease the prescribing challenges and rational use of drugs in this special population.
Ms Shilpa Palaksha
Associate Professor
JSS College of Pharmacy, JSS AHER, Mysuru
Presenter
Biography
Shilpa Palaksha currently working as Associate Professor at Department of Pharmacy Practice, JSS College of Pharmacy, JSS AHER, Mysuru. She has 18 years of experience in various fields including clinical research, academic research and medical writing. Her thrust areas are Health related quality of life, Health Outcome research, Drug Allergy, Medical device associated adverse events, pharmacovigilance. Has presented and published her research in various national and international journals. Guided 18 research students. Been an contributing author for chapters on respiratory medicine.
Dr. Jisha Myalil Lucca
Asst. professor
Gulf medical University
Presenter
Biography
Dr. Jisha Myalil Lucca, Assistant Professor in Pharmacy Practice at the,Gulf medicl university UAE. With a robust career spanning over two decades, Dr. Lucca has significantly contributed to the fields of pharmacy education, clinical pharmacy, and research.
Her research interests are diverse, covering pharmacovigilance, cosmovigilance, hemovigilance, drug safety, substance abuse, and child psychiatry. Dr. Lucca has a prolific publication record, with numerous peer-reviewed articles in reputed journals. She has been honored with multiple awards, including the Young Investigator Award at the 15th Indo-Malaysian International Conference and research grants from DST and JSS University.In addition to her academic and research endeavors, Dr. Lucca is an active member of several professional organization
Moderator
Frank May
ISPE
Krishna Undela
Assistant Professor
National Institute of Pharmaceutical Education and Research (NIPER) Guwahati
